Amgen Inc. (AMGN) Presents at Special Call (IR Call) Conference Transcript
https://seekingalpha.com/article/4796742-amgen-inc-amgn-presents-at-special-call-ir-call-conference-transcript?source=feed_sector_transcripts
Jun 23, 2025 -
0
Members of Congress Are Pouring Millions Into These 7 Surprising Stocks
https://www.fool.com/investing/2025/06/17/members-of-congress-are-pouring-millions-into-thes/?source=iedfolrf0000001
Jun 17, 2025 -
0
4 stocks to watch on Friday: XOM, CVX, AMGN and TTWO
https://seekingalpha.com/news/4440138-4-stocks-to-watch-on-friday-xom-cvx-amgn-and-ttwo?source=feed_sector_healthcare
May 02, 2025 -
0
Down 12.3% at One Point in a Single Trading Session, Is Amgen Stock Still a Buy?
https://www.fool.com/investing/2024/11/30/down-123-at-one-point-in-a-single-trading-session/?source=iedfolrf0000001
Nov 30, 2024 -
0
Amgen (AMGN) Q3 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/10/30/amgen-amgn-q3-2024-earnings-call-transcript/?source=iedfolrf0000001
Oct 30, 2024 - AMGN earnings call for the period ending September 30, 2024.
0
2 Top Dividend Stocks to Buy Hand Over Fist Right Now
https://www.fool.com/investing/2024/10/11/2-top-dividend-stocks-to-buy-hand-over-fist-right/?source=iedfolrf0000001
Oct 11, 2024 - Income stocks can be wise additions to your portfolio in any market environment.
0
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $500
https://www.fool.com/investing/2024/09/13/2-unstoppable-growth-stocks-to-buy-right-now-for/?source=iedfolrf0000001
Sep 13, 2024 - Growth-oriented businesses can make excellent additions to a well-diversified portfolio.
0
VRDN Stock Soars as Eye Disorder Study Meets Primary Endpoints
https://www.zacks.com/stock/news/2334732/vrdn-stock-soars-as-eye-disorder-study-meets-primary-endpoints?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334732
Sep 11, 2024 - The phase III THRIVE study evaluating Viridian's veligrotug for treating active thyroid eye disease meets all primary and secondary endpoints.
0
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
https://www.zacks.com/stock/news/2334185/terns-stock-soars-on-positive-data-from-phase-i-study-of-obesity-drug?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2334185
Sep 10, 2024 - TERN stock soars on positive data from the early-stage study of TERN-601 for obesity, showing statistically significant weight reduction compared to placebo.
0
3 Unstoppable Dividend Stocks to Buy Right Now
https://www.fool.com/investing/2024/08/25/3-unstoppable-dividend-stocks-to-buy-right-now/?source=iedfolrf0000001
Aug 25, 2024 - These stocks are the A-team for income investors.
0
Page 1>